27 results
DEFM14A
FUSN
Fusion Pharmaceuticals Inc
25 Apr 24
Proxy related to merger
4:13pm
of Innovation, Science and Industry has not sent to Parent a notice under subsection 25.2(1) of the Investment Canada Act within the prescribed time period … , have elapsed from the date of certification of the notification and (2) (A) the Minister of Innovation, Science and Industry has not sent to Parent
PREM14A
FUSN
Fusion Pharmaceuticals Inc
10 Apr 24
Preliminary proxy related to merger
4:42pm
of Innovation, Science and Industry has not sent to Parent a notice under subsection 25.2(1) of the Investment Canada Act within the prescribed time … the Investment Canada Act, have elapsed from the date of certification of the notification and (2) (A) the Minister of Innovation, Science and Industry
DEFA14A
FUSN
Fusion Pharmaceuticals Inc
19 Mar 24
Additional proxy soliciting materials
6:25am
) the Minister of Innovation, Science and Industry has not sent to the Parent a notice under subsection 25.2(1) of the Investment Canada Act within
8-K
EX-2.1
0hb3xci7p5g
19 Mar 24
Voting and Support Agreement
6:24am
8-K
EX-99.1
f8d hsw05
13 Aug 21
Fusion Pharmaceuticals and TRIUMF Announce Expanded R&D
4:11pm
8-K
EX-10.1
l3zig5 satme9
3 Jun 21
Fusion Pharmaceuticals Enters into Agreement to Build
7:30am
DEF 14A
2ie2s86dsdeht8
27 Apr 21
Definitive proxy
4:02pm
10-K
e0x0vyo58fsoo3vja7f
25 Mar 21
Annual report
8:01am
8-K
EX-10.1
nvfklmch
2 Mar 21
Fusion Pharmaceuticals to Expand Pipeline with Acquisition of IPN-1087, a Small Molecule Targeting NTSR1, from Ipsen
9:00am
10-Q
fomwbh4n
11 Aug 20
Quarterly report
4:05pm
424B4
moe5vrc00s2foh
26 Jun 20
Prospectus supplement with pricing info
4:47pm
S-1/A
iw7euzug tnsm
22 Jun 20
IPO registration (amended)
6:16am